Download PDF
1 / Pages

Other users also viewed these articles

Biological Dose Tapering in Daily Clinical Practice: A 10 Year Follow-up Study Mercedes Alperi-López; Sara Alonso-Castro; Isla Morante-Bolado; Rubén Queiro-Silva; José Luis Riestra-Noriega; Luis Arboleya; Francisco Javier Ballina-García;
Reumatol Clin. 2020;16P1:319-23
A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis Alberto Jiménez-Morales; Rafael Cáliz; Susana Aceituno; Miriam Prades; Carles Blanch;
Reumatol Clin. 2021;17:536-42
Psoriasis induced by biological therapy Lydia Montolio Chiva; Àngels Martínez Ferrer; Almudena Mateu Puchades; Cristina Campos Fernández; Javier Narváez Garcia; Juan José Alegre Sancho;
Reumatol Clin. 2021;17:437-9